Fractyl Health, Inc. (GUTS): R&D Expense

Annual figures by period end, from SEC filings.

$74.54M

Year ended 2025-12-31

$63.36M

Trailing 12 months to 2026-06-30

2023-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$74.54M	+5.8%	2026-03-24, From 2025-01-01
2024-12-31	$70.47M	+85.3%	2026-03-24, From 2024-01-01
2023-12-31	$38.04M	n/a	2025-03-03, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Fractyl Health, Inc. (GUTS)	2025-12-31	$74.54M	+5.8%
Baxter International Inc (BAX)	2025-12-31	$518.00M	-12.2%
Becton Dickinson & Co (BDX)	2025-09-30	$1.26B	+6.3%
3M Co (MMM)	2024-12-31	$700.00M	0.0%
Teleflex Inc (TFX)	2025-12-31	$144.78M	+32.8%
West Pharmaceutical Services Inc (WST)	2025-12-31	$74.30M	+7.5%
Stryker Corp (SYK)	2025-12-31	$1.62B	+10.7%
Haemonetics Corp (HAE)	2026-03-28	$59.77M	-4.7%
KORU Medical Systems, Inc. (KRMD)	2025-12-31	$4.39M	-16.6%

Compare GUTS, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗